(41) reported that CLL cells express relatively normal levels of total CD79a and IgM and proposed that deficient CD79b expression leads to decoupling with CD79a and IgM, which blocks BcR assembly and reduces surface IgM expression in CLL cells (41). The gene discussed is CD79A; the disease is B-cell chronic lymphocytic leukemia.